Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma

British Journal of Haematology

Volumn 133, Issue 6, 2006, Pages 634-637

  Song, Kevin W ^a   Barnett, Michael J ^a   Gascoyne, Randy D ^b   Horsman, Douglas E ^b   Forrest, Donna L ^a   Hogge, Donna E ^a   Lavoie, Julyle C ^a   Nantel, Stephen H ^a   Nevill, Thomas J ^a   Shepherd, John D ^a   Smith, Clayton A ^a   Sutherland, Heather J ^a   Voss, Nicholas J ^b   Toze, Cynthia L ^a   Connors, Joseph M ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Burkitt lymphoma; Chemotherapy; Stem cell transplant

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANADA; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; CYTOGENETICS; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BURKITT LYMPHOMA; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 33646709184     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06080.x     Document Type: Article

References (8)

1. Fisher R.I. Gaynor E.R. Dahlberg S. Oken M.M. Grogan T.M. Mize E.M. Glick J.H. Coltman Jr. C.A. Miller T.P. 1993 Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma New England Journal of Medicine 328 1002 1006
2. van Imhoff G.W. van der Holt B. MacKenzie M.A. Ossenkoppele G.J. Wijermans P.W. Kramer M.H. van't Veer M.B. Schouten H.C. van Marwijk Kooy M. van Oers M.H. Raemaekers J.M. Sonneveld P. Meulendijks L.A. Kluin P.M. Kluin-Nelemans H.C. Verdonck L.F. 2005 Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma Leukemia 19 945 952
3. Ladenstein R. Pearce R. Hartmann O. Patte C. Goldstone T. Philip T. 1997 High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry Blood 90 2921 2930
4. Lee E.J. Petroni G.R. Schiffer C.A. Freter C.E. Johnson J.L. Barcos M. Frizzera G. Bloomfield C.D. Peterson B.A. 2001 Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251 Journal of Clinical Oncology 19 4014 4022
5. Magrath I. Adde M. Shad A. Venzon D. Seibel N. Gootenberg J. Neely J. Arndt C. Nieder M. Jaffe E. Wittes R.A. Horak I.D. 1996 Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen Journal of Clinical Oncology 14 925 934
6. Magrath I.T. Venkatesh H. Gascoyne R.D. 2004 Burkitt's Lymphoma In Non-Hodgkin's Lymphomas ed. by Mauch P.M. pp 477 502 Lippincott Williams & Wilkins Philadelphia, PA
7. Peniket A.J. Ruiz de Elvira M.C. Taghipour G. Cordonnier C. Gluckman E. de Witte T. Santini G. Blaise D. Greinix H. Ferrant A. Cornelissen J. Schmitz N. Goldstone A.H. 2003 An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation Bone Marrow Transplantation 31 667 678
8. Sweetenham J.W. Pearce R. Taghipour G. Blaise D. Gisselbrecht C. Goldstone A.H. 1996 Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma-outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation Journal of Clinical Oncology 14 2465 2472